7 results
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... #DOAC #Bridging ... #Dosing #Oral # ... #Rivaroxaban #Edoxaban ... #Loading #DVT #Pharmacology
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... ) for VTE treatment ... Table #DOAC ... #Management #Pharmacology ... #Comparison #Table
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
direct-acting oral ... for appropriate dosing ... direct-acting oral ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... #DOAC #Dosing #Oral ... Anticoagulation #Comparison ... #Table #Pharmacology
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Rivaroxaban Oral ... patients with VTE ... indications and edoxaban ... rivaroxaban for VTE ... #Pharmacology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
**Edoxaban is initiated ... bleeding risk during ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
direct acting oral ... per treatment table ... inhibitor) • Apixaban ... , Edoxaban, Rivaroxaban ... Management #Treatment #pharmacology